ArticleAnnals of translational medicine2021

A multicenter single-arm trial of sintilimab in combination with chemotherapy for neoadjuvant treatment of resectable esophageal cancer (SIN-ICE study).

Hongtao Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.